“…Different pharmaceutical technologies and formulation strategies were preliminarily screened for the preparation of RZ sustained-release tablets, such as direct compression using conventional and highfunctionality excipients, dry-granulation, and wet-granulation using pH-independent polymers only, but only wet-and melt-granulation techniques using a blend of multifunctional polymers with controlled microenvironmental pH, showed the best results in terms of in-vitro drug release and comparative dissolution (data not shown). The basic principle of the wet-granulation technique relies on holding powder particles together using an aqueous, alcoholic, hydroalcoholic, or buffered binder solution, while the melt-granulation technique is based on incorporating a melt binder in the tablet preparation [29,30]. F1-F5 formulas were prepared by wet granulation technique, using Eudragit ® L100-55, Methocel ™ E5, and Avicel ® PH-101 intra-granularly, and carnauba wax powder extra-granularly, while F6-F10 formulas prepared by a melt-granulation technique using carnauba wax powder intra-granularly, and Eudragit ® L100-55, Methocel ™ E5, and Avicel ® PH-101 extra-granularly.…”